Click to copy
Click to copy

Alder BioPharmaceuticals: 2Q Earnings Snapshot

August 6, 2019

BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Tuesday reported a loss of $58.4 million in its second quarter.

The Bothell, Washington-based company said it had a loss of 72 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 99 cents per share.

Alder BioPharmaceuticals shares have declined 11% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.11, a decrease of 53% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR

All contents © copyright 2019 The Associated Press. All rights reserved.